Mechanism of action

Learn about how Epitherapeutics used NGS to elucidate the mechanism of action for their drug.

Epitherapeutics is developing novel innovative cancer drugs based on world leading research in epigenetics.


A Danish pharmaceutical company, Epitherapeutics, had developed a promising novel, epigenetically-functioning cancer drug. Its molecular mechanism of action needed to be elucidated


Using RNA-sequencing data from cancer cell lines treated with the drug alongside untreated controls, we constructed a computational pipeline for discovering the genes and pathways involved in the mechanism.


The development team understood how the drug alters the epigenome of the cancer cells. The customer was able to convince buyers of its potential for clinical investigations.

Do you want to learn more about this case? Please ask for more from our bioinformatician by using the contact form below!